PATHWARE INC.
Software for real-time quality assessment of tissue biopsies at the point of collection
- Sector
- Medtech
- Headquarters
- Golden, CO
- Founded
- 2017
- Latest Form D
- $8.1M, Oct 2021
- Total capital
- $13M
- Federal grants
- $895K
- 3 awards · 2022–2023
- Rank in peer group#70 of 477
- Private capital raised
- $12.1M
- 4 Form D · last Oct 2021
- 60 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 4 pending · first 2022
- Rank in peer group#99 of 477
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Leveraging Label-Free Digital Imaging to Enable Rapid On-Site Evaluation (ROSE) During Thyroid Biopsy Procedures$400K
- Federal grantHealth and Human S · Phase I · Harnessing Coded Ptychography to Deliver AI-powered Evaluation of Unstained Lung Biopsies at the Point-Of-Care$96K
- Federal grantHealth and Human S · Phase I · Harnessing Coded Ptychography to Deliver AI-powered Evaluation of Unstained Lung Biopsies at the Point-Of-Care$400K
- Private capital raisedForm D · SEC · 4th filing$8.1M
- Private capital raisedForm D · SEC · 3rd filing$2.5M
- Private capital raisedForm D · SEC · 2nd filing$1.1M
- Private capital raisedForm D · SEC · 1st filing$365K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#70 · top 15%
- Granted patents#99 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Austin Derek DukeDirectorNamed in SEC Form D filings
- Derek ThomasDirectorNamed in SEC Form D filings
- Jaron NixExecutive Officer, DirectorNamed in SEC Form D filings
- John """TJ""" MeyerExecutive Officer, DirectorNamed in SEC Form D filings
- Michael MooreExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Michael Derek ThomasDirectorNamed in SEC Form D filings
Show all 8 people
- Richard PhilpottDirectorNamed in SEC Form D filings
- Rodger MooreDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 7- GrantedPoint- Of-care- Computational Microscopy Based-systems And MethodsUSPTOUS 12,228,723
- GrantedComputational Microscopy Based-system And Method For Automated Imaging And Analysis Of Pathology SpecimensUSPTOUS 11,927,738
- GrantedComputational Microscopy Based-system And Method For Automated Imaging And Analysis Of Pathology SpecimensUSPTOUS 11,347,046
Show all 7 patent records
- Point- Of-care- Computational Microscopy Based-systems And MethodsFeb 18, 2025 · US 12,228,723Granted
- Computational Microscopy Based-system And Method For Automated Imaging And Analysis Of Pathology SpecimensMar 12, 2024 · US 11,927,738Granted
- Computational Microscopy Based-system And Method For Automated Imaging And Analysis Of Pathology SpecimensMay 31, 2022 · US 11,347,046Granted
- Computational Microscopy Based-system And Method For Automated Imaging And Analysis Of Pathology SpecimensApplication PCTUS2019066842Pending
- Point-of-care Devices And Methods For Biopsy AssessmentApplication 63476444Pending
- Point-of-care Devices And Methods For Biopsy AssessmentApplication PCTUS2023083867Pending
- Point-of-care Devices And Methods For Biopsy AssessmentApplication 19140144Pending
Related companies, and why
- REMASTERED SLEEP LLCSimilar federal contract value in Medtech · null in contracts
- PHD SKIN CARE LLCSimilar federal contract value in Medtech · null in contracts
- IONOPTIX, LLCSimilar federal contract value in Medtech · null in contracts
- Prehensile TechnologiesSimilar federal contract value in Medtech · null in contracts
- PULSAR LIFE SCIENCES, INC.Similar federal contract value in Medtech · null in contracts
- IMVARIA INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .